Gregory Bailey, Director at Medivation, holds 1.62M shares in Biohaven Ltd. (Ticker: BHVN), holds 63.38K shares in Serina Therapeutics (Ticker: SER), holds 1.31M shares in Biohaven Pharmaceutical Holding Co (Ticker: ~BHVN). Most recently, Gregory Bailey Bought ― shares of Biohaven Ltd. on Sep 25, 2024 for an estimated value of 220.95K.
Gregory Bailey latest transaction was an Informative Buy of $220.95K.
What was Gregory Bailey's most profitable transaction?
Gregory Bailey’s most profitable transaction was an Informative Buy of BHVN stock on October 26, 2022. The return on the trade was 105.60%.
What is Gregory Bailey's role in Medivation?
Gregory Bailey's role in Medivation is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.